Fucoidan and Liver Fibrosis
Author Information
Author(s): Shinji Hayashi, Ayano Itoh, Katsuhiro Isoda, Masuo Kondoh, Masaya Kawase, Kiyohito Yagi
Primary Institution: Graduate School of Pharmaceutical Sciences, Osaka University
Hypothesis
Can fucoidan attenuate hepatic fibrosis induced by CCl4?
Conclusion
Fucoidan may be a promising anti-fibrotic agent that protects hepatocytes and inhibits hepatic stellate cell proliferation.
Supporting Evidence
- Fucoidan reduced liver injury markers AST and ALT in mice.
- Fucoidan administration significantly decreased the fibrotic area in the liver.
- Fucoidan protected hepatocytes from CCl4-induced cell death.
Takeaway
Fucoidan, a substance from brown algae, helps protect liver cells and may stop liver scarring.
Methodology
The study used animal models to assess the effects of fucoidan on liver injury and fibrosis induced by CCl4.
Limitations
The study was conducted in animal models, which may not fully represent human conditions.
Participant Demographics
Male Sprague–Dawley rats and male ddy mice were used in the experiments.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website